PATENT CLAIM ANALYSIS

Application Number: 15875757
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "093600"]

Abstract:
An oncolytic herpes simplex virus is disclosed for use in a method of treating cancer, the method comprising administering one or more doses of an oncolytic herpes simplex virus effective to induce a Th1 immune response in the subject, and optionally administering a therapeutically effective amount of an immune checkpoint inhibitor.

Claim (Index 23):
The oncolytic herpes simplex virus or immune checkpoint inhibitor for use in a method of treating cancer according to any one of  claims 18  to  22  wherein administration of the oncolytic herpes simplex virus is for a period of time prior to treatment with an immune checkpoint inhibitor in which period the subject is administered oncolytic herpes simplex virus but is not administered an immune checkpoint inhibitor.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.42105
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15557783', '16068816', '16068823', '16068826', '14374619']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7567243466179578
- 35 USC 102 Novelty (BERT): 0.5418604542636857
- Combined Prediction Score: 0.7352379573825307
- Mean Citation Score: 355.01183000000015
- Max Citation Score: 397.81573
- Similarity Product: 266.62444488243216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test